Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 12, 2018
Effect of lidocaine on kanamycin injection-site pain in patients with multidrug-resistant tuberculosisR G Court, L Wiesner, M T Chirehwa, et al.
Lancet (London, England)|May 18, 2004
Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised studyK I Barnes, J Mwenechanya, M Tembo, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2007
Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smearsA H Diacon, R F Patientia, A Venter, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 30, 2013
Pharmacometrics: opportunity for reducing disease burden in the developing world: the case of AfricaG Pillai, G Davies, P Denti, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 10, 2015
Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosisR Dawson, K Narunsky, D Carman, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 15, 2013
The pharmacokinetics of nevirapine when given with isoniazid in South African HIV-infected individualsE H Decloedt, J Mwansa-Kambafwile, J-S van der Walt, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 12, 2016
Bioavailability of two licensed paediatric rifampicin suspensions: implications for quality control programmesH McIlleron, H Hundt, W Smythe, et al.
Antimicrobial Agents and Chemotherapy|February 6, 2023
Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic ModelingM T Chirehwa, J E Resendiz-Galvan, R Court, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 23, 2021
Pharmacokinetics of high-dose isoniazid in children affected by multidrug-resistant TBJ L Winckler, H S Schaaf, H R Draper, et al.
Clinical Pharmacology and Therapeutics|August 12, 2015
Pediatric tuberculous meningitis: Model-based approach to determining optimal doses of the anti-tuberculosis drugs rifampin and levofloxacin for childrenR M Savic, R Ruslami, J E Hibma, et al.
Pageof 3